Jonathan Krinsky, BTIG chief market technician, joins CNBC's Closing Bell to discuss market outlooks.

Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (NasdaqGS:ACRS) from Neutral ...

BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...

BTIG Research has recently initiated Douglas Elliman Inc (DOUG) stock to Neutral rating, as announced on July 18, 2023, according to Finviz. Analyst ratings are significant because they provide ...

Energy and Infrastructure Transition Analyst Lewis holds a virtual meeting with management on November 22 hosted by BTIG. Don't Miss out on Research Tools: Discover the latest stocks recommended by ...

BTIG Research began coverage on shares of VYNE Therapeutics (NASDAQ:VYNE – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat.com reports. The brokerage set a ...

Ensuring the US doesn’t default on its obligations. Extending trillions of dollars in tax cuts before they expire.

Donald Trump has been somewhat cagey about his economic plans — especially tariffs — since voters elected him president. That ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

On Tuesday, Upstart Holdings Inc (UPST) stock saw a modest uptick, ending the day at $71.11 which represents a slight increase of $2.84 or 4.16% from the prior close of $68.27. The stock opened at $67 ...

Donald Trump has been somewhat cagey about his economic plans — especially tariffs — since voters elected him president. That ...

“Donald Trump cares about independent validators. And the biggest independent validator of his success is the market. It’s a ...